FSA Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$7.13K Hold
73
﹤0.01% 347
2025
Q2
$7.84K Hold
73
﹤0.01% 326
2025
Q1
$7.36K Hold
73
﹤0.01% 312
2024
Q4
$6.52K Hold
73
﹤0.01% 360
2024
Q3
$6.12K Buy
+73
New +$5.75K ﹤0.01% 377
2024
Q1
$5K Hold
73
﹤0.01% 449
2023
Q4
$4K Buy
+73
New +$3.9K ﹤0.01% 450
2021
Q1
Sell
-300
Closed -$11K 79
2020
Q4
$11K Buy
+300
New +$10.8K 0.01% 255
2020
Q3
Sell
-300
Closed -$11K 104
2020
Q2
$11K Hold
300
0.01% 256
2020
Q1
$10K Hold
300
0.01% 241
2019
Q4
$14K Buy
+300
New +$12.6K 0.01% 265

Other funds holding BSX

FSA Wealth Management's BSX Position: Q3 2025 in Review

FSA Wealth Management held its Boston Scientific (BSX) position steady in Q3 2025 at 73 shares worth $7.13K. The position accounts for ﹤0.01% of the portfolio, ranked #347.

FSA Wealth Management first reported a position in BSX in Q4 2019 and has held it in 11 quarters since. The position peaked at $14K in Q4 2019. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • FSA Wealth Management held 73 shares of Boston Scientific worth $7.13K as of Q3 2025.
  • FSA Wealth Management left its Boston Scientific share count unchanged in Q3 2025.
  • Boston Scientific made up ﹤0.01% of FSA Wealth Management's portfolio in Q3 2025, its #347 holding.
  • FSA Wealth Management first reported a position in Boston Scientific in Q4 2019 and has held it in 11 quarters since.
  • FSA Wealth Management's Boston Scientific position peaked at $14K in Q4 2019.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on FSA Wealth Management's 13F filing for Q3 2025, filed 17 Nov 2025.